Industry News
One Year On Herceptin For Breast Cancer Ideal
Oct 01, 2012
Patients in early-stage HER2-positive breast cancer should remain on Herceptin (trastuzumab) treatment for one year, and not two years or six months, according to a final analysis of the Phase III HERA trial, pharmaceutical company Roche and the Breast International Group announced today... Read More
Mouse Model Sees Reduction In Deadly Complication Of Stem Cell Transplants
Oct 01, 2012
Studying leukemia in mice, researchers at Washington University School of Medicine in St. Louis have reduced a life-threatening complication of stem cell transplants, the only curative treatment when leukemia returns... Read More
Better Detectiom Of High-Grade Prostate Cancers With Less Biopsies, With Contrast-Enhanced Ultrasound
Oct 01, 2012
Microbubble technique could serve as another monitoring tool for active surveillance in low-grade cancer patients, say Thomas Jefferson University researchers Contrast-enhanced ultrasound was found to better detect high-grade prostate cancer than conventional methods, making it a more appropriate approach for screening clinically important cancers and monitoring low-risk one... Read More
Researchers Find Possible Molecular Key To Regulation Of Ovarian Cancer Stem Cells
Oct 01, 2012
Researchers at Moffitt Cancer Center have discovered that the micro ribonucleic acid miR-214 plays a critical role in regulating ovarian cancer stem cell properties. This knowledge, said the researchers, could pave the way for a therapeutic target for ovarian cancer. The study appears in a recent issue of the The Journal of Biological Chemistry. According to the study's lead author, Jin Q... Read More
Researchers Aim To Eliminate Invasive Cervical Cancer
Oct 01, 2012
Researchers at Moffitt Cancer Center and colleagues at the University of South Florida and The Ohio State University have published a paper in the September issue of Cancer Epidemiology, Biomarkers & Prevention that provides an overview on preventing invasive cervical cancer... Read More
Mouse Model Sees Reduction In Deadly Complication Of Stem Cell Transplants
Oct 01, 2012
Studying leukemia in mice, researchers at Washington University School of Medicine in St. Louis have reduced a life-threatening complication of stem cell transplants, the only curative treatment when leukemia returns... Read More
Researchers Find Possible Molecular Key To Regulation Of Ovarian Cancer Stem Cells
Oct 01, 2012
Researchers at Moffitt Cancer Center have discovered that the micro ribonucleic acid miR-214 plays a critical role in regulating ovarian cancer stem cell properties. This knowledge, said the researchers, could pave the way for a therapeutic target for ovarian cancer. The study appears in a recent issue of the The Journal of Biological Chemistry. According to the study's lead author, Jin Q... Read More
Researchers Aim To Eliminate Invasive Cervical Cancer
Oct 01, 2012
Researchers at Moffitt Cancer Center and colleagues at the University of South Florida and The Ohio State University have published a paper in the September issue of Cancer Epidemiology, Biomarkers & Prevention that provides an overview on preventing invasive cervical cancer... Read More
The First Ever Estimate Of The Economic Burden Of Cancer In Europe Shows That It Exceeds 124 Billion Euros
Oct 01, 2012
New studies that reveal for the first time the real economic and human costs of caring for cancer patients in Europe will be presented during the ESMO 2012 Congress of the European Society for Medical Oncology in Vienna... Read More
Better Detectiom Of High-Grade Prostate Cancers With Less Biopsies, With Contrast-Enhanced Ultrasound
Oct 01, 2012
Microbubble technique could serve as another monitoring tool for active surveillance in low-grade cancer patients, say Thomas Jefferson University researchers Contrast-enhanced ultrasound was found to better detect high-grade prostate cancer than conventional methods, making it a more appropriate approach for screening clinically important cancers and monitoring low-risk one... Read More
Previous Page Next Page